Hypercapnic Hyperventilation to Accelerate Emergence from Inhaled Volatile Anesthetics: A Practical Method Using Standard Hospital Equipment

Summary

This protocol demonstrates a practical method to induce controlled hypercapnic hyperventilation using standard anesthesia equipment. The technique facilitates rapid emergence from volatile anesthesia by accelerating anesthetic washout via elevated CO₂ levels and enhanced ventilation, providing a feasible alternative when proprietary commercial systems are unavailable.

Abstract

Hypercapnic hyperventilation is a technique used to support emergence from volatile anesthesia by allowing a controlled elevation of arterial carbon dioxide (CO₂) levels. The resulting hypercapnia increases minute ventilation, enhances the washout of anesthetic gases from the lungs, and increases cerebral blood flow, which may facilitate faster elimination of volatile agents from brain tissue. Commercial devices have been developed to achieve this effect; however, their availability is limited in many regions. This protocol describes a practical alternative approach using standard anesthesia equipment commonly available in European hospitals. By temporarily removing the CO₂ absorber and reducing fresh gas flow, controlled CO₂ rebreathing is facilitated, while an active charcoal filter eliminates residual volatile anesthetics from the circuit. The protocol provides step-by-step guidance to help achieve the desired end-tidal CO₂ levels safely and efficiently. This method offers a practical and low-cost way to induce hypercapnic hyperventilation, which may be associated with faster emergence from anesthesia under appropriate clinical conditions.

Introduction

Recently, there has been an increased focus on approaches aimed at facilitating emergence from general anesthesia¹. Delayed emergence and residual anesthetic effects remain clinically relevant challenges, particularly when rapid neurological assessment and operating room efficiency are desired. One of these approaches is hypercapnic hyperventilation. Hypercapnic hyperventilation is a controlled anesthetic emergence technique in which arterial carbon dioxide (CO₂) levels are deliberately elevated to enhance minute ventilation and is thought to facilitate the washout of volatile anesthetics at the end of surgery^2,3,4,5,6,7. By inducing mild hypercapnia, this approach increases cerebral blood flow^8,9 and is associated with stimulation of the respiratory centers in the brainstem, which may support the return to spontaneous ventilation and consciousness. The overall goal of the method is to shorten the time to support timely awakening and extubation after volatile anesthesia while maintaining patient safety and minimizing residual anesthetic effects.

Conventional emergence strategies rely primarily on high fresh gas flows to eliminate volatile anesthetics. Although effective, this can be time-consuming and may not optimally support cerebral elimination of anesthetic agents. This represents a largely passive elimination strategy that does not actively engage physiological mechanisms known to influence anesthetic clearance. Hypercapnic hyperventilation aims to address these limitations by coupling two physiological mechanisms—CO₂-mediated respiratory drive and increased cerebral perfusion⁹—that are thought to enhance anesthetic clearance from both pulmonary and cerebral compartments. Clinical studies have suggested that this strategy can significantly reduce emergence times and improve recovery quality compared to standard approaches.

A commercial system is available which utilizes an extendable rebreathing loop in combination with an active charcoal filter device⁷. This device integrates rebreathing and anesthetic gas scavenging within a single-use system designed to accelerate anesthetic elimination. However, this device is currently not widely available in Europe and other regions, limiting its clinical adoption. As a result, despite supportive evidence in the literature, the practical application of this technique remains limited in many clinical settings.

The present protocol describes a practical and accessible alternative for inducing hypercapnic hyperventilation using standard anesthesia equipment commonly available in most European hospitals. By removing the CO₂ absorber and reducing the fresh gas flow, controlled rebreathing is facilitated, while an active charcoal filter eliminates residual volatile anesthetics from the breathing loop. This method allows anesthesia providers to replicate the physiological benefits of hypercapnic hyperventilation without specialized commercial devices¹⁰. This protocol, therefore, aims to bridge the gap between the technique as described in the literature and its feasibility in daily clinical practice.

In addition to its simplicity and low cost, this approach offers an educational advantage by allowing clinicians to explore the physiological interplay between ventilation, CO₂ retention, and anesthetic elimination. The described technique is appropriate for adult patients without contraindications to transient hypercapnia, such as elevated intracranial pressure or pulmonary hypertension. When applied under proper monitoring and within defined safety limits, hypercapnic hyperventilation may represent an additional option in the modern anesthesia emergence repertoire, allowing readers to assess whether this method is suitable for their clinical environment and patient population.

Protocol

This procedure is performed in compliance with institutional human research ethics and anesthesia practice guidelines. Apply this method only to patients in whom transient hypercapnia is not contraindicated, such as those without elevated intracranial pressure or pulmonary hypertension. Continuous monitoring of oxygen saturation, end-tidal CO₂, anesthetic gas concentration, and hemodynamics is required throughout the procedure. The data shown are anonymized monitoring data from a single patient and were used in accordance with institutional policies regarding the educational or scientific use of clinical data. At hospital admission, patients provide broad consent for such use of their anonymized medical data (“consent at admission”); therefore, no study-specific informed consent or separate ethics approval was required.

NOTE: Patient selection criteria: Adult patients undergoing elective surgery under volatile anesthesia with expected standard emergence and stable intraoperative hemodynamics. Exclusion criteria: Do not apply this protocol to patients with intracranial hypertension, severe pulmonary hypertension, or uncompensated cardiac disease. Additional contraindications include any condition in which transient hypercapnia is considered unsafe based on established clinical indications and intraoperative anesthesiologist judgment. The hypercapnic hyperventilation protocol is initiated at the end of the surgical procedure, after cessation of surgical stimulation, when the clinician determines that emergence can be initiated.

CAUTION: Prior to initiating the procedure, verify that the anesthesia workstation allows safe modification of the breathing circuit, including temporary removal or bypass of the CO₂ absorber during ongoing mechanical ventilation. Ensure familiarity with the specific ventilator settings and alarm functions of the device in use. Confirm availability of continuous monitoring of airway pressure, ventilation parameters, and gas exchange throughout the procedure.

1. Preparation of the anesthesia circuit

NOTE: Disposal of used active charcoal filters should follow local institutional protocols for waste management of single-use anesthetic devices and materials potentially contaminated with volatile anesthetic agents.

1. Turn off the volatile anesthetic vaporizer and ensure that no anesthetic agent is being delivered to the circuit.
2. Set the inspired oxygen fraction (FiO₂) to 1.0 by adjusting the anesthesia machine oxygen blender to deliver 100% oxygen.
3. Reduce the fresh gas flow (FGF) to approximately 0.2 L·min⁻¹ using the flow control knobs on the anesthesia machine to promote rebreathing within the circuit.
4. Attach a single active charcoal filter (as listed in Table of Materials) to the inspiratory limb of the anesthesia circuit immediately distal to the Y-piece, ensuring correct directional orientation according to manufacturer instructions as shown in Figure 1A–C.
5. Confirm correct placement by verifying a secure, airtight connection without leaks and ensuring unidirectional gas flow through the filter.
6. Refill the breathing circuit with 100% oxygen in case of unwanted disconnection as advised by the manufacturer (i.e., 1–2 s flush of the O₂ button or temporary increase of fresh gas flow for 3–4 s to 15 L·min⁻¹).
   NOTE: Some institutions permit limited reuse of active charcoal filters under defined conditions; adhere strictly to local policies regarding reuse and disposal.
7. Disconnect the CO₂-absorbing canister (soda lime) from the anesthesia machine to allow CO₂ accumulation within the breathing loop, as shown in Figure 1D–E.
   NOTE: Ensure that the CO₂ absorber is completely bypassed or removed; partial removal may result in unpredictable CO₂ levels. Confirm correct configuration by verifying that the absorber is fully excluded from the breathing circuit (no gas flow through the canister) and by visual inspection of the bypass position before proceeding. Visually check that the bypass lever is in the correct position, and confirm the expected rise in end-tidal CO₂ after initiating rebreathing before proceeding.
8. During initiation of hypercapnic hyperventilation, continuously monitor inspired volatile anesthetic concentration.
   NOTE: Under low fresh gas flow (0.2 L·min⁻¹), a rapid decline of inspired volatile anesthetic concentration to near-zero levels (<0.1 vol%) is expected within approximately 1–2 min. If inspired concentrations remain detectable beyond this period, replace the active charcoal filter immediately before continuing the protocol.
9. Confirm that all circuit connections are airtight and that the anesthesia machine displays normal pressure and flow readings before proceeding.

2. Inducing hypercapnic hyperventilation

1. General approach
   1. Apply the protocol in either mechanically ventilated or spontaneously breathing patients, depending on intraoperative ventilation status at the end of surgery.
2. Mechanically ventilated patients
   1. Set mechanical ventilation to achieve controlled hypercapnia.
   2. Increase tidal volume to 8–10 mL·kg⁻¹ ideal body weight and adjust minute ventilation to 10–12 L·min⁻¹.
   3. NOTE: These adjustments are operator-controlled and are used to regulate CO₂ levels indirectly by modifying alveolar ventilation. Avoid relying solely on respiratory rate adjustments, as tidal volume changes are more effective for controlled CO₂ retention.
3. Reduce fresh gas flow (see 1.3) and remove the CO₂ absorber (see 1.4) to allow controlled CO₂ accumulation. In this setting, rising CO₂ levels stimulate the respiratory drive, resulting in a physiological increase in minute ventilation without external ventilator adjustments.
4. CO₂ monitoring and adjustment of fresh gas flow
   1. Continuously monitor end-tidal CO₂ (EtCO₂) via capnography.
   2. Adjust fresh gas flow (FGF) in a stepwise and titrated manner based on real-time CO₂ trends.
   3. Increase FGF in small increments of approximately 0.1–0.3 L·min⁻¹ when EtCO₂ exceeds the target range (7.0–7.3 kPa; 52.5–55 mmHg).
   4. Reassess EtCO₂ within 1–2 min after each adjustment to evaluate response.
   5. Decrease FGF to a minimum of approximately 0.2 L·min⁻¹ when EtCO₂ is below the target range to facilitate CO₂ accumulation.
   6. Avoid abrupt or large adjustments to prevent overshooting and instability of CO₂ levels.
   7. Maintain FGF within a low-flow range (0.2–1.0 L·min⁻¹) throughout the procedure, titrated according to continuous capnographic feedback.
      NOTE: The induced hypercapnia is intended to be transient and limited to the emergence phase of anesthesia. The target end-tidal CO₂ range (7.0–7.3 kPa; 52.5–55 mmHg) is typically maintained for several minutes during anesthetic washout and is discontinued immediately upon return of adequate spontaneous ventilation and clinical signs of emergence.
5. Stabilization: Increase fresh gas flow slightly (e.g., from 0.2 to 0.5 L·min⁻¹) once the target EtCO₂ range is reached to stabilize CO₂ levels.
   NOTE: Avoid excessive CO₂ accumulation (>8.0–8.5 kPa) to reduce the risk of respiratory acidosis or sympathetic overactivation.

3. Maintenance and monitoring

1. Maintain FiO₂ at 0.7–1.0 during the entire procedure.
2. Continue monitoring of inspiratory and expiratory volatile anesthetic concentrations using a calibrated gas analyzer (see Figure 2 for a representative monitor display).
3. Observe the patient’s hemodynamics, oxygenation, and ventilation parameters until the inspired volatile anesthetic concentration decreases to zero.
4. Assess for the return of spontaneous breathing and clinical signs of emergence (e.g., eye opening, purposeful movement, or response to verbal commands).
5. Once the patient demonstrates adequate conditions, proceed with extubation according to standard institutional criteria.

4. Post-procedure steps

1. Remove the active charcoal filter from the inspiratory limb immediately after completion of the protocol and prior to preparation for the next case.
2. To reduce the risk of human error, verify visually and physically that the filter has been removed and that the standard circuit configuration has been restored.
   CAUTION: Failure to remove the active charcoal filter can result in unintended adsorption of anesthetic gases and intraoperative awareness during subsequent cases¹¹.
3. Reconnect or reinstall the CO₂ absorber (soda lime) before initiating anesthesia for the next case.
4. Confirm correct function by verifying normal CO₂ absorption and stable baseline capnography before induction. To mitigate omission risk, incorporate this step into the standard anesthesia machine checkout procedure between cases.
   CAUTION: Failure to restore the CO₂ absorber can result in unintended rebreathing and intraoperative hypercapnia during subsequent cases. Given the critical nature of circuit modification, explicit post-procedure circuit checks are recommended. A standardized “return-to-baseline” verification of the anesthesia machine configuration should be performed before the next case to ensure that all temporary components are removed and the standard settings are restored.

5. Safety and troubleshooting

1. Immediately terminate hypercapnic hyperventilation by increasing fresh gas flow to 10 L·min⁻¹ if any of the following occur: oxygen desaturation (SpO₂ < 94%), hemodynamic instability (e.g., hypotension requiring intervention or clinically relevant arrhythmia), or excessive hypercapnia (EtCO₂ > 8.5 kPa; 64 mmHg) despite corrective measures.
2. After termination, immediately restore conventional anesthesia conditions by reinstalling the CO₂ absorber, returning fresh gas flow to standard settings, and resuming conventional ventilation parameters appropriate for the patient and anesthetic phase.
   CAUTION: If unexpected resistance, leaks, or abnormal capnography values occur, inspect the breathing circuit, connectors, and the orientation of the active charcoal filter. Verify an airtight assembly and correct unidirectional flow through the filter before continuing the procedure. This protocol should only be performed by anesthesia providers experienced in mechanical ventilation, capnography interpretation, and volatile anesthetic management.

6. Pause points

CAUTION: The procedure can be paused after completion of step 1.6 (circuit setup) before induction of hypercapnic hyperventilation, if necessary. Do not pause the procedure once CO₂ accumulation has started. Continuous patient monitoring is mandatory during active hypercapnia.

Results

This section demonstrates the physiological and clinical effects of the hypercapnic hyperventilation technique in a representative case. As shown in Figure 1, the experimental setup enables controlled bypass of the CO₂ absorber and integration of an active charcoal filter, thereby allowing simultaneous CO₂ rebreathing and volatile anesthetic scavenging. This configuration forms the basis for the observed physiological changes with controlled CO₂ elevation and accelerated anesthetic washout (...

Discussion

The presented protocol describes a practical approach to inducing hypercapnic hyperventilation using standard anesthesia equipment. The critical steps for implementation include complete removal or bypassing of the CO₂ absorber, reduction of fresh gas flow to approximately 0.2 L·min⁻¹, and continuous monitoring of end-tidal CO₂ (EtCO₂). Accurate control of CO₂ accumulation is important for reaching the target range of 7.0–7.3 kPa (52.5–55 mmHg) without exceeding s...

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
Disposable CO2 absorber, IS Can™, Spherasorb™	Intersurgical, Workingham, United Kingdom	2196000	Disposable CO2 absorber canister, removed during the procedure
Dräger Atlan A350	Drägerwerk, Lübeck, Germany	8621500	Standard mechanical ventilator with circle breathing system, capnography and anesthetic gas analysis
IntelliVue X3 patient monitor	Philips, Eindhoven, The Netherlands	X3 867030	Standard patient monitoring module (ECG, SpO2, NIBP)
Vapor-Clean filter	Dynasthetics, Salt Lake City, USA	SKU 101	www.dynasthetics.com/Vapor-Clean/